This book delves into the management of hepatocellular carcinoma (HCC) in low to middle-income countries. Shockingly, a projected 1.3 million people are at risk of dying from liver cancer by 2040, marking a 56.4% increase from 2020. HCC cases and deaths are expected to rise by over 50% in the next two decades.
The book discusses HCC management in low to middle-income countries with limited healthcare budgets and resources as the cost of therapeutic options for HCC, such as liver resection, transplantation, ablative therapies, transarterial embolotherapy/radiotherapy, systemic therapy, and palliative care vary significantly and can be substantial.
The book also emphasizes the role of the prevention of HCC. It is suitable for specialists in surgical oncology, medical oncology, radiation oncology, hepatology, gastroenterology, interventional radiology and surgery. It is also relevant for specialists in general medicine, public health, epidemiology, family medicine besides medical students, trainees and specialized nurses.
It aligns with UN SDG 3 - Good Health and Well-Being.
Les informations fournies dans la section « Synopsis » peuvent faire référence à une autre édition de ce titre.
Vendeur : BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, Allemagne
Taschenbuch. Etat : Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -This book delves into the management of hepatocellular carcinoma (HCC) in low to middle-income countries. Shockingly, a projected 1.3 million people are at risk of dying from liver cancer by 2040, marking a 56.4% increase from 2020. HCC cases and deaths are expected to rise by over 50% in the next two decades.The book discusses HCC management in low to middle-income countries with limited healthcare budgets and resources as the cost of therapeutic options for HCC, such as liver resection, transplantation, ablative therapies, transarterial embolotherapy/radiotherapy, systemic therapy, and palliative care vary significantly and can be substantial.The book also emphasizes the role of the prevention of HCC. It is suitable for specialists in surgical oncology, medical oncology, radiation oncology, hepatology, gastroenterology, interventional radiology and surgery. It is also relevant for specialists in general medicine, public health, epidemiology, family medicine besides medical students, trainees and specialized nurses.It aligns with UN SDG 3 - Good Health and Well-Being. 336 pp. Englisch. N° de réf. du vendeur 9789819638963
Quantité disponible : 2 disponible(s)
Vendeur : moluna, Greven, Allemagne
Etat : New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. N° de réf. du vendeur 3836702982
Quantité disponible : Plus de 20 disponibles
Vendeur : AHA-BUCH GmbH, Einbeck, Allemagne
Taschenbuch. Etat : Neu. Druck auf Anfrage Neuware - Printed after ordering - This book delves into the management of hepatocellular carcinoma (HCC) in low to middle-income countries. Shockingly, a projected 1.3 million people are at risk of dying from liver cancer by 2040, marking a 56.4% increase from 2020. HCC cases and deaths are expected to rise by over 50% in the next two decades.The book discusses HCC management in low to middle-income countries with limited healthcare budgets and resources as the cost of therapeutic options for HCC, such as liver resection, transplantation, ablative therapies, transarterial embolotherapy/radiotherapy, systemic therapy, and palliative care vary significantly and can be substantial.The book also emphasizes the role of the prevention of HCC. It is suitable for specialists in surgical oncology, medical oncology, radiation oncology, hepatology, gastroenterology, interventional radiology and surgery. It is also relevant for specialists in general medicine, public health, epidemiology, family medicine besides medical students, trainees and specialized nurses.It aligns with UN SDG 3 - Good Health and Well-Being. N° de réf. du vendeur 9789819638963
Quantité disponible : 1 disponible(s)
Vendeur : preigu, Osnabrück, Allemagne
Taschenbuch. Etat : Neu. Approach to Hepatocellular Carcinoma (HCC) Management in Low/Middle-Income Countries | Reda Elwakil (u. a.) | Taschenbuch | vii | Englisch | 2026 | Springer | EAN 9789819638963 | Verantwortliche Person für die EU: Springer Verlag GmbH, Tiergartenstr. 17, 69121 Heidelberg, juergen[dot]hartmann[at]springer[dot]com | Anbieter: preigu. N° de réf. du vendeur 136154094
Quantité disponible : 5 disponible(s)
Vendeur : buchversandmimpf2000, Emtmannsberg, BAYE, Allemagne
Taschenbuch. Etat : Neu. This item is printed on demand - Print on Demand Titel. Neuware -This book delves into the management of hepatocellular carcinoma (HCC) in low to middle-income countries. Shockingly, a projected 1.3 million people are at risk of dying from liver cancer by 2040, marking a 56.4% increase from 2020. HCC cases and deaths are expected to rise by over 50% in the next two decades.The book discusses HCC management in low to middle-income countries with limited healthcare budgets and resources as the cost of therapeutic options for HCC, such as liver resection, transplantation, ablative therapies, transarterial embolotherapy/radiotherapy, systemic therapy, and palliative care vary significantly and can be substantial.The book also emphasizes the role of the prevention of HCC. It is suitable for specialists in surgical oncology, medical oncology, radiation oncology, hepatology, gastroenterology, interventional radiology and surgery. It is also relevant for specialists in general medicine, public health, epidemiology, family medicine besides medical students, trainees and specialized nurses.It aligns with UN SDG 3 - Good Health and Well-Being.Springer Verlag GmbH, Tiergartenstr. 17, 69121 Heidelberg 344 pp. Englisch. N° de réf. du vendeur 9789819638963
Quantité disponible : 1 disponible(s)